Noah Goodman, Chief Business Officer: Kymera Therapeutics KYMR Planned sale · Filed 06/25

Trade details

Type: Planned sale notice
Stock: Kymera Therapeutics KYMR
Person: Noah GoodmanChief Business Officer
Planned sale date: 26/06/25
Filed: 26/06/25

More to sell after $1.3M in 3 months

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 05/26~07/25

Noah Goodman's recent trades

Noah GoodmanChief Business Officer
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$388.6K
3,389 sh
$388.6K
Filed 07/01
Traded 07/01
Noah GoodmanChief Business Officer
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$297.5K
2,500 sh
$297.5K
Filed 06/25
Traded 06/25
Noah GoodmanChief Business Officer
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$272.5K
2,500 sh
$272.5K
Filed 06/25
Traded 06/25
Noah GoodmanChief Business Officer
Sell10b5-1 planKymera Therapeutics
Sell10b5-1 plan
Kymera Therapeutics
KYMR
$247.5K
2,500 sh
$247.5K
Filed 06/22
Traded 06/22
Noah GoodmanChief Business Officer
Planned sale10b5-1 planKymera Therapeutics
Planned sale10b5-1 plan
Kymera Therapeutics
KYMR
$226.1K
2,500 sh
$226.1K
Filed 06/22
Traded 06/22

Noah Goodman, Chief Officer — plans to sell 5,000 sh of Kymera Therapeutics KYMR · $499.4K · around 06/25 · 10b5-1 plan | Whalegun